CVS Health Corporation (CVS)
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS Health (CVS) is a Great Momentum Stock: Should You Buy?
Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Low Price-to-Book Stocks That Are Worth Buying in June
STNE, USNA, STRA, NEXA and CVS passed a low price-to-book screen, combining discounted valuations with projected long-term EPS growth.
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Trump's Economy Hired Nearly 1 Million Healthcare Workers While Every Other Sector Lost Jobs. Here's Where to Put Your Money
Economist Justin Wolfers dropped a number on the Prof G Markets podcast that should reorganize how you think about the 2026 economy.
CVS Offers A Compelling Turnaround Opportunity Not Seen In Years
CVS Health faced intense investor scrutiny in 2024 and 2025 amid efforts to recover from a downturn but has since turned things around. Q1 2026 results showed that the insurance business is exploding for CVS. CVS also posted other positive signs of growth, such as improved retail pharmacy market share.
Has CVS Health (CVS) Outpaced Other Medical Stocks This Year?
Here is how CVS Health (CVS) and Align Technology (ALGN) have performed compared to their sector so far this year.
Medicare Advantage Continues To Grow Despite Health Insurer Exits
Despite some high-profile retreats by health insurers from Medicare Advantage, the privatized medical coverage for older adults continues to add health plan members and is now the choice of 55% of eligible beneficiaries, a new report shows.
CVS Health (CVS) Advances While Market Declines: Some Information for Investors
The latest trading day saw CVS Health (CVS) settling at $95.93, representing a +1.17% change from its previous close.
CVS Health (CVS) Up 8.5% Since Last Earnings Report: Can It Continue?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
